N-[4-[[8-(2,6-difluoroanilino)-9-(oxan-4-yl)purin-2-yl]amino]cyclohexyl]methanesulfinamide
C23H29F2N7O2S — CID 143262171
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[[8-(2,6-difluoroanilino)-9-(oxan-4-yl)purin-2-yl]amino]cyclohexyl]methanesulfinamide
N-[4-[[8-(2,6-difluoroanilino)-9-(oxan-4-yl)purin-2-yl]amino]cyclohexyl]methanesulfinamide (PubChem CID 143262171) has the molecular formula C23H29F2N7O2S and a molecular weight of 505.60 g/mol. Its IUPAC name is N-[4-[[8-(2,6-difluoroanilino)-9-(oxan-4-yl)purin-2-yl]amino]cyclohexyl]methanesulfinamide.
Molecular Properties
| Compound Name | N-[4-[[8-(2,6-difluoroanilino)-9-(oxan-4-yl)purin-2-yl]amino]cyclohexyl]methanesulfinamide |
|---|---|
| PubChem CID | 143262171 |
| Molecular Formula | C23H29F2N7O2S |
| Molecular Weight | 505.60 g/mol |
| Exact Mass | 505.21 |
| IUPAC Name | N-[4-[[8-(2,6-difluoroanilino)-9-(oxan-4-yl)purin-2-yl]amino]cyclohexyl]methanesulfinamide |
| SMILES | CS(=O)NC1CCC(Nc2ncc3nc(Nc4c(F)cccc4F)n(C4CCOCC4)c3n2)CC1 |
| InChI | InChI=1S/C23H29F2N7O2S/c1-35(33)31-15-7-5-14(6-8-15)27-22-26-13-19-21(30-22)32(16-9-11-34-12-10-16)23(28-19)29-20-17(24)3-2-4-18(20)25/h2-4,13-16,31H,5-12H2,1H3,(H,28,29)(H,26,27,30) |
| InChIKey | KTMCLQDQASMYEW-UHFFFAOYSA-N |
| XLogP | 3.81 |
| TPSA | 105.99 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 505.60 |
| LogP ≤ 5 | 3.81 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143262171 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.